PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma. Issue 1 (29th November 2019)
- Record Type:
- Journal Article
- Title:
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma. Issue 1 (29th November 2019)
- Main Title:
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- Authors:
- Ma, Jiaqiang
Zheng, Bohao
Goswami, Shyamal
Meng, Lu
Zhang, Dandan
Cao, Chunmei
Li, Teng
Zhu, Fangming
Ma, Lijie
Zhang, Zhao
Zhang, Shuhao
Duan, Meng
Chen, Qin
Gao, Qiang
Zhang, Xiaoming - Abstract:
- Abstract : Background: CD8 + T cells differentiate into exhausted status within tumors, including hepatocellular carcinoma (HCC), which constitutes a solid barrier to effective anti-tumor immunity. A detailed characterization of exhausted T cells and their prognostic value in HCC is lacking. Methods: We collected fresh tumor tissues with adjacent non-tumor liver tissues and blood specimens of 56 HCC patients, as well as archived samples from two independent cohorts of HCC patients ( n = 358 and n = 254), who underwent surgical resection. Flow cytometry and multiplex immunostaining were used to characterize CD8 + T cells. Patient prognosis was evaluated by Kaplan-Meier analysis and Cox regression analysis. Results: CD8 + T cells were classified into three distinct subpopulations: PD1 Hi, PD1 Int and PD1 − . PD1 Hi CD8 + T cells were significantly enriched in tumor compared to adjacent non-tumor liver tissues. PD1 Hi CD8 + T cells highly expressed exhaustion-related inhibitory receptors (TIM3, CTLA-4, etc.) and transcription factors (Eomes, BATF, etc.). In addition, PD1 Hi CD8 + T cells expressed low levels of cytotoxic molecules and displayed a compromised capacity to produce pro-inflammatory cytokines while the expression of anti-inflammatory IL-10 was up-regulated following mitotic stimulation. Furthermore, PD1 Hi CD8 + T cells shared features with tissue resident memory T cells and were also characterized in an aberrantly activated status with an apoptosis-proneAbstract : Background: CD8 + T cells differentiate into exhausted status within tumors, including hepatocellular carcinoma (HCC), which constitutes a solid barrier to effective anti-tumor immunity. A detailed characterization of exhausted T cells and their prognostic value in HCC is lacking. Methods: We collected fresh tumor tissues with adjacent non-tumor liver tissues and blood specimens of 56 HCC patients, as well as archived samples from two independent cohorts of HCC patients ( n = 358 and n = 254), who underwent surgical resection. Flow cytometry and multiplex immunostaining were used to characterize CD8 + T cells. Patient prognosis was evaluated by Kaplan-Meier analysis and Cox regression analysis. Results: CD8 + T cells were classified into three distinct subpopulations: PD1 Hi, PD1 Int and PD1 − . PD1 Hi CD8 + T cells were significantly enriched in tumor compared to adjacent non-tumor liver tissues. PD1 Hi CD8 + T cells highly expressed exhaustion-related inhibitory receptors (TIM3, CTLA-4, etc.) and transcription factors (Eomes, BATF, etc.). In addition, PD1 Hi CD8 + T cells expressed low levels of cytotoxic molecules and displayed a compromised capacity to produce pro-inflammatory cytokines while the expression of anti-inflammatory IL-10 was up-regulated following mitotic stimulation. Furthermore, PD1 Hi CD8 + T cells shared features with tissue resident memory T cells and were also characterized in an aberrantly activated status with an apoptosis-prone potential. In two independent cohorts of HCC patients ( n = 358 and n = 254), we demonstrated that PD1 Hi or TIM3 + PD1 Hi CD8 + T cells were significantly correlated with poor prognosis, and the latter was positioned in close proximity to PD-L1 + tumor associated macrophages. Conclusion: The current study unveils the unique features of PD1 Hi CD8 + exhausted T cells in HCC, and also suggests that exhausted T cells could act as a biomarker to select the most care-demanding patients for tailored therapies. … (more)
- Is Part Of:
- Journal for immunotherapy of cancer. Volume 7:Issue 1(2019)
- Journal:
- Journal for immunotherapy of cancer
- Issue:
- Volume 7:Issue 1(2019)
- Issue Display:
- Volume 7, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 7
- Issue:
- 1
- Issue Sort Value:
- 2019-0007-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-11-29
- Subjects:
- Hepatocellular carcinoma -- CD8+ T cells -- T cell exhaustion -- Multiplex immunohistochemistry -- Spatial analysis
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105 - Journal URLs:
- http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s40425-019-0814-7 ↗
- Languages:
- English
- ISSNs:
- 2051-1426
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22300.xml